secwatch.observer — SEC 8-K summary
======================================

Issuer:     CapForce Inc. (CFOR)
CIK:        0001293818
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001079973-23-000064
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OpGen closes $7.5M public offering of common stock and warrants
---------------------------------------------------------------

- Sold 2,586,207 shares/common or pre-funded warrants, plus Series A-1 and A-2 warrants at $2.90 per combined unit.
- Gross proceeds approximately $7.5M; net proceeds to fund commercialization of Acuitas AMR Gene Panel and Unyvero Platform.
- Proceeds also allocated to Ares Genetics development, sales/marketing, manufacturing infrastructure, and debt repayment.
- H.C. Wainwright acted as exclusive placement agent, receiving 6.0% cash fee.
- Offering closed on January 11, 2023 under effective S-1 registration statement (File No. 333-268648).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293818/000107997323000064/0001079973-23-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293818/000107997323000064/opgen_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer